Suerie Moon
Direktor/Vorstandsmitglied bei Drugs for Neglected Diseases initiative
Profil
Suerie Moon is currently the Secretary & Director at Drugs for Neglected Diseases initiative and an Instructor-Public Health at Harvard University.
Previously, she worked as the Director at Médecins Sans Frontières USA, Inc. She holds a doctorate degree from Harvard University, an undergraduate degree from Yale University, and a graduate degree from Princeton University.
Aktive Positionen von Suerie Moon
Unternehmen | Position | Beginn |
---|---|---|
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 22.11.2010 |
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative BiotechnologyHealth Technology Drugs for Neglected Diseases initiative provides drug research and development services. It specializes in analyzing the causes of and in developing medicine and treatments for neglected diseases. It specializes in the study of neglected tropical diseases, such as sleeping sickness (Human African Trypanosomiasis), Leishmaniasis, Chagas, malaria, pediatric HIV, and filarial diseases. It develops a research and development portfolio that includes projects from discovery through to post-registration phases. Its focus areas encompass regional disease-specific platform development, technology transfer, and public responsibility and awareness advocacies. The organization was founded in July 2003 and is headquartered in Geneva, Switzerland. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Suerie Moon
Unternehmen | Position | Ende |
---|---|---|
Médecins Sans Frontières USA, Inc.
Médecins Sans Frontières USA, Inc. Miscellaneous Commercial ServicesCommercial Services Médecins Sans Frontières USA, Inc. delivers emergency medical assistance. The firm has branch offices operate in Argentina, Czech Republic, India, Ireland, Mexico, South Korea and United Arab Emirates. The company was founded by Pascal Greletty-Bosviel , Gérard Illiouz, Bernard Kouchner, Gérard Pigeon, Vladan Radoman, Max Recamier, Jean-Michel Wild, Jacques Beres, Jacques Beres, Raymond Borel, Jean Cabrol, Marcel Delcourt, Xavier Emmanuelli on December 22, 1971 and is headquartered in New York, NY. | Direktor/Vorstandsmitglied | - |
Ausbildung von Suerie Moon
Harvard University | Doctorate Degree |
Yale University | Undergraduate Degree |
Princeton University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Médecins Sans Frontières USA, Inc.
Médecins Sans Frontières USA, Inc. Miscellaneous Commercial ServicesCommercial Services Médecins Sans Frontières USA, Inc. delivers emergency medical assistance. The firm has branch offices operate in Argentina, Czech Republic, India, Ireland, Mexico, South Korea and United Arab Emirates. The company was founded by Pascal Greletty-Bosviel , Gérard Illiouz, Bernard Kouchner, Gérard Pigeon, Vladan Radoman, Max Recamier, Jean-Michel Wild, Jacques Beres, Jacques Beres, Raymond Borel, Jean Cabrol, Marcel Delcourt, Xavier Emmanuelli on December 22, 1971 and is headquartered in New York, NY. | Commercial Services |
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative BiotechnologyHealth Technology Drugs for Neglected Diseases initiative provides drug research and development services. It specializes in analyzing the causes of and in developing medicine and treatments for neglected diseases. It specializes in the study of neglected tropical diseases, such as sleeping sickness (Human African Trypanosomiasis), Leishmaniasis, Chagas, malaria, pediatric HIV, and filarial diseases. It develops a research and development portfolio that includes projects from discovery through to post-registration phases. Its focus areas encompass regional disease-specific platform development, technology transfer, and public responsibility and awareness advocacies. The organization was founded in July 2003 and is headquartered in Geneva, Switzerland. | Health Technology |